Filing Details
- Accession Number:
- 0001729197-18-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-11 17:22:21
- Reporting Period:
- 2018-12-10
- Accepted Time:
- 2018-12-11 17:22:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534120 | Cerecor Inc. | CERC | Pharmaceutical Preparations (2834) | 450705648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1729197 | V Matthew Phillips | C/O Cerecor Inc. 400 E. Pratt Street, Suite 606 Baltimore MD 21202 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-10 | 497 | $2.85 | 497 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $1.13 | 2027-11-17 | 100,000 | 100,000 | Direct | |
Common Stock | Stock Option (right to buy) | $3.21 | 2028-01-22 | 100,000 | 100,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-11-17 | 100,000 | 100,000 | Direct |
2028-01-22 | 100,000 | 100,000 | Direct |
Footnotes
- These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
- The grant shall vest one-fourth on each of the first, second, third and fourth anniversaries of the date of grant, provided Mr. Phillips is then an officer of the Company.